Search Results - "STO Saad"

Refine Results
  1. 1

    EVALUATING THE PRO-APOPTOTIC AND ANTIOXIDANT EFFECTS OF HESPERIDIN AND HESPERETIN IN LEUKEMIA CELL LINES by IC Rocha, NG Amôr, STO Saad, MC Alvarez

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…The proliferative state of cancer cells, characterized by uncontrolled division and evasion of programmed cell death, is a hallmark of malignancy. Citrus…”
    Get full text
    Journal Article
  2. 2

    THE MCL-1 INHIBITOR AZD5991 DISPLAYS A PROMISING TARGETED THERAPY FOR ACUTE MYELOID LEUKEMIA by MLP Bueno, STO Saad, FM Roversi

    Published in Hematology, Transfusion and Cell Therapy (01-10-2021)
    “…Aims: MCL-1 protein is an anti-apoptotic member of BCL-2 protein family. In hematological neoplasms, increased MCL-1 gene expression or protein activity is…”
    Get full text
    Journal Article
  3. 3

    EGCG INDUCES AN INFLAMMATORY PROFILE REDUCING M2 MACROPHAGES IN A MOUSE MODEL OF MDS by FID Via, MC Alvarez, KP Ferro, I Santos, NG Amôr, STO Saad

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Epigallocatechin-3-gallate (EGCG), a polyphenol extracted from green tea, has shown a range of beneficial effects, including the inhibition of M2 macrophage…”
    Get full text
    Journal Article
  4. 4

    TP53 GENE EXPRESSION IS INCREASED AND CORRELATES WITH RHOC IN PATIENTS WITH ACUTE MYELOID LEUKEMIA by BA Rodrigues, SSC Sampaio, KA Lima, GRS Mendonça, STO Saad, M Lazarini

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Background: Mutations in the tumor suppressor gene TP53 are found in approximately 10% of acute myeloid leukemia (AML) cases and are associated with a worse…”
    Get full text
    Journal Article
  5. 5

    EXPLORING THE EFFICACY OF GALLIC ACID IN INDUCING APOPTOSIS AND MODULATING ROS IN MYELOID AND LYMPHOID LEUKEMIA CELL LINES by GV Romano, ICF Silva, I Rocha, NG Amòr, STO Saad, MC Alvarez

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Leukemia is the fifth most prevalent cancer worldwide. Despite significant progress in treatment through new drugs, side effects remain a major challenge…”
    Get full text
    Journal Article
  6. 6

    RHOA KNOCKDOWN AFFECTS P53 SUBCELLULAR LOCALIZATION IN LEUKEMIA CELLS IRRADIATED WITH UVC by AD Ferreira, SSC Sampaio, PSSM Ferrari, ASS Duarte, CRR Rocha, STO Saad, M Lazarini

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introduction and aims: Acute myeloid leukemia (AML) is a severe hematological malignancy with low rates of survival. Mutations in the tumor suppressor gene…”
    Get full text
    Journal Article
  7. 7

    POTENTIAL EFFECTS OF CITRUS FLAVONOIDS HESPERIDIN AND ITS AGLYCONE HESPERETIN IN LEUKEMIA CELL LINE by IC Rocha, RGB Gomes, NG Amôr, STO Saad, MC Alvarez

    Published in Hematology, Transfusion and Cell Therapy (01-10-2023)
    “…Acute Myeloid Leukemia (AML) is a prevalent form of leukemia, responsible for an alarming 62% of all fatalities related to leukemia globally, and the current…”
    Get full text
    Journal Article
  8. 8

    A NOVEL IN VITRO BONE MARROW NICHE PLATFORM FOR INVESTIGATING THERAPEUTIC STRATEGIES FOR ACUTE LEUKEMIAS by DP Echevarria, MLP Bueno, I Santos, NG Amôr, FM Roversi, AN Bruno, STO Saad

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Aims: Acute lymphoblastic leukemia (ALL), the most prevalent childhood cancer, disrupts the hematopoietic bone marrow (BM) niche, a specialized…”
    Get full text
    Journal Article
  9. 9

    PRIMARY EXTRANODAL LYMPHOMA EFFORT (PELÉ): COMPARISON OF PUBLIC AND PRIVATE HEALTH CARE ASSISTANCE, FROM A BRAZILIAN MULTICENTER OBSERVATIONAL STUDY by ALC Mendonça, BB Silva, G Duffles, F Galvão, E Rizzo, E Miranda, LL Perruso, RLR Baptista, STO Saad, CA Souza

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Objective: Compare public healthcare (Pub) with private healthcare (Pri) in Brazilian patients with primary extranodal lymphoma. Methods: PELÉ is a multicenter…”
    Get full text
    Journal Article
  10. 10

    A MULTICENTER ANALYSIS OF PRIMARY GASTRIC LYMPHOMA IN BRAZILIAN CENTERS: FIRST RESULTS OF THE PELÉ STUDY (PRIMARY EXTRANODAL LYMPHOMA EFFORT) by BB Silva, ALC Mendonça, G Duffles, F Galvão, E Rizzo, E Miranda, LL Perruso, RLR Baptista, STO Saad, CA Souza

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Objective: Evaluate clinical and epidemiological characteristics of patients with primary gastric lymphoma (PGL) within the PELÉ study. Methods: PELÉ is a…”
    Get full text
    Journal Article
  11. 11

    INVESTIGATING THE IMPACT OF EGCG ON INEFFECTIVE HEMATOPOIESIS IN A MDS MOUSE MODEL by FID Via, KP Ferro, GR Assis-Mendonça, P Latuf-Filho, I Santos, NG Amôr, FVP Souza, MC Alvarez, STO Saad

    Published in Hematology, Transfusion and Cell Therapy (01-10-2023)
    “…Background and aims: Green tea catechins, particularly, epigallocatechin-3-gallate (EGCG), exhibit a range of beneficial effects, like apoptosis and…”
    Get full text
    Journal Article
  12. 12

    PIEZO1 ACTIVATION INCREASES NEUTROPHIL ADHESIVE PROPERTIES IN SICKLE CELL ANEMIA by FC Leonardo, PL Brito, S Egée, E Nader, P Connes, STO Saad, FF Costa, N Conran

    Published in Hematology, Transfusion and Cell Therapy (01-10-2023)
    “…Sickle cell anemia (SCA) is an inherited disorder caused by a mutation in the gene encoding β-globin. This mutation brings about alterations in the hemoglobin…”
    Get full text
    Journal Article
  13. 13

    RHOC EXPRESSION CORRELATES WITH SRC AND IT IS A PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA by B Contieri, LB Paiva, GB Silva, DFV Ramos, JCL Silva, JAM Neto, STO Saad, M Lazarini

    Published in Hematology, Transfusion and Cell Therapy (01-10-2021)
    “…Introduction: Acute Myeloid Leukemia (AML) is a hematologic malignancy with poor prognosis that can occur from myelodysplastic syndrome (MDS) progression. RHOC…”
    Get full text
    Journal Article
  14. 14

    O SILENCIAMENTO DE RHOA PROVOCA ALTERAÇÕES EM LARGA ESCALA NA EXPRESSÃO GÊNICA GLOBAL DE CÉLULAS DE LEUCEMIA by MCC Ramalho, SSC Sampaio, ASS Duarte, STO Saad, M Lazarini

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introdução: RHOA é uma proteína Rho GTPase crucial no controle da dinâmica do citoesqueleto. Além disso, Rho GTPases também regulam a expressão gênica. A…”
    Get full text
    Journal Article
  15. 15

    IMPACTO DO SILENCIAMENTO DAS PROTEÍNAS RHOA E RHOC NA NA AQUISIÇÃO DE DANOS AO DNA E MORTE DE CÉLULAS MIELOIDES U937 TRATADAS COM UVC by SSC Sampaio, CS Souza, BA Rodrigues, AD Ferreira, ASS Duarte, STO Saad, M Lazarini

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introdução: RhoA e RhoC são proteínas RHO GTPases homólogas que desempenham papéis cruciais na regulação de processos celulares, incluindo a apoptose e a…”
    Get full text
    Journal Article
  16. 16

    O SILENCIAMENTO DA PROTEÍNA RHO GTPASE RHOA INDUZ MUDANÇAS NA EXPRESSÃO DE REGULADORES DO CICLO CELULAR E APOPTOSE EM LINHAGEM CELULAR DE LEUCEMIA MIELOIDE AGUDA by CS Souza, SSC Sampaio, MCC Ramalho, GRS Mendonça, ASS Duarte, STO Saad, CRR Rocha, M Lazarini

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Introdução e objetivos: RHOA e RHOC são proteínas homólogas pertencentes à subfamília RHO das GTPases, desempenhando papéis centrais em processos celulares…”
    Get full text
    Journal Article
  17. 17

    AVALIAÇÃO DA EFICÁCIA DE SUPLEMENTAÇÃO DE CONCENTRADOS DE HEMÁCIAS PARA FINS TRANSFUSIONAIS: ESTUDOS DE VIABILIDADE CELULAR E PARÂMETROS BIOQUÍMICOS by LNG Carvalho, FF Costa, MT Mesquita, STO Saad, SE Jorge, TT Jorge

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Objetivos: investigar a qualidade dos concentrados de hemácias suplementados com 2,3-bifosfoglicerato (2,3-BPG), hexafosfato de inositol (IHP) e…”
    Get full text
    Journal Article
  18. 18

    ESTUDO PROSPECTIVO DE COMPOSTOS PARA MELHORIA DE FUNÇÃO DA HEMOGLOBINA EM CONCENTRADO DE HEMÁCIAS by MT Mesquita, LNG Carvalho, TT Jorge, STO Saad, FF Costa, SE Jorge

    Published in Hematology, Transfusion and Cell Therapy (01-10-2024)
    “…Objetivo: Avaliar a eficácia funcional da hemoglobina (Hb) em concentrado de hemácias (CH) em bolsas de sangue suplementadas com 2,3-Bifosfoglicerato…”
    Get full text
    Journal Article
  19. 19

    TERAPIA DE FOTOBIOMODULAÇÃO NO TRATAMENTO DE ÚLCERAS DE MEMBROS EM PACIENTES COM ANEMIA FALCIFORME: RELATO DE CASO E IMPACTO NA ANALGESIA E REGENERAÇÃO TECIDUAL by FGOM Manoel, PM Campos, SS Medina, STO Saad, BD Benites

    Published in Hematology, Transfusion and Cell Therapy (01-10-2023)
    “…Objetivos: Úlceras de membros configuram como uma das mais complexas manifestações das doenças falciformes (DF), com imenso impacto biopsicossocial: dor…”
    Get full text
    Journal Article
  20. 20

    EXPRESSÃO DE PODOPLANINA POR CITOMETRIA DE FLUXO IDENTIFICA COM PRECISÃO PACIENTES COM LEUCEMIA PROMIELOCÍTICA AO DIAGNÓSTICO by CMA Saraiva, CRP Moraes, BKL Duarte, PM Campos, GB Oliveira, STO Saad, EV Paula

    Published in Hematology, Transfusion and Cell Therapy (01-10-2023)
    “…Introdução: Leucemia promielocítica aguda (LPA) é uma emergência que exige diagnóstico e tratamento imediatos. A suspeita se baseia na morfologia, podendo ser…”
    Get full text
    Journal Article